Alzheimer’s-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions

Szaruga, Maria, Munteanu, Bogdan, Lismont, Sam, Veugelen, Sarah, Horré, Katrien, Mercken, Marc, Saido, Takaomi C., Ryan, Natalie S. +9 more·2017·Cell
DOI 10.1016/j.cell.2017.07.004

Cited by (249)

Items 201–249 of 249

  1. Transient cholesterol interactions with the amyloid precursor protein involved in Alzheimer’s disease pathogenesis
    Veronika V. Zlobina, Vladimir A. Mitkevich, Yaroslav V. Bershatsky, Pavel E. Volynsky, Konstantin V. Pavlov, Mikhail S. Karbyshev, Ivan S. Okhrimenko, Sergey A. Kozin, Roman G. Efremov, Alexander А. Makarov et al. · 2025 · Biophysical Reviews
  2. Autosomal Dominant Alzheimer’s Disease Mutations in Human Microglia Are Not Sufficient to Trigger Amyloid Pathology in WT Mice but Might Affect Pathology in 5XFAD Mice
    Carmen Romero‐Molina, Sarah M. Neuner, Marcelina Ryszawiec, Alice Pébay, Dominantly Inherited Alzheimer Network, Edoardo M. Marcora, Alison Goate · 2024 · International Journal of Molecular Sciences
  3. Not all plaques are created equal: Uncovering a unique molecular signature in Alzheimer’s disease
    Kristján Holt, Emily Payne, Tara L. Spires‐Jones · 2024 · Brain and Neuroscience Advances
  4. Mutations in PSEN1 predispose inflammation in an astrocyte model of familial Alzheimer’s disease through disrupted regulated intramembrane proteolysis
    Oliver Jonathan Ziff, Sarah Jolly, Jackie M. Casey, Lucy Granat, Satinder K. Samra, Núria Setó‐Salvia, Argyro Alatza, Leela Phadke, Benjamin Galet, Philippe Ravassard et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Amyloid neuropathy, tauopathy, decreased cholinergic and dopaminergic neurons, long-term memory and motor deficits, and sleep disturbance in motopsin deficient mice
    Fumiaki Yokoi, Yuuna Tanaka, Akari Sakai, Nao Isogai, Shiori Miyata, Shinichi Mitsui · 2025 · GeroScience
  6. Pharmacology of nivegacetor (RG6289), a potent and selective gamma secretase modulator in clinical development for the treatment of Alzheimer’s disease
    Lothar Lindemann, Julie Lambotte, Judith Rothe, Jürg Messer, Catherine Diener, Solen Pichereau, Carina Cantrill, Thomas Mueggler, Michael Honer, Jennifer Beck et al. · 2026 · Frontiers in Pharmacology
  7. From mechanism to substratome: Unraveling mysteries of γ-secretase
    Harald Steiner, Stephan Breimann, Frits Kamp, Dmitrij Frishman · 2026 · Journal of Biological Chemistry
  8. A Survey of Genetic Risk Factors for Alzheimer’s Disease
    Aanya Kamath · 2023 · Journal of Student Research
  9. Dissecting Conformational Changes in APP’s Transmembrane Domain Linked to ε-Efficiency in Familial Alzheimer’s Disease
    Alexander Götz, Christina Scharnagl · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Structural Modeling of γ -Secretase A β n Complex Formation and Substrate Processing
    Manuel Hitzenberger, Martin Zacharias · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Dimeric Transmembrane Orientations of APP/C99 Regulate γ-Secretase Processing Line Impacting Signaling and Oligomerization
    Florian Perrin, Nicolas Papadopoulos, Rémi Opsomer, Devkee M. Vadukul, Céline Vrancx, Nathalie Pierrot, Steven O. Smith, Didier Vertommen, Pascal Kienlen‐Campard, Stefan N. Constantinescu · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Plasma Aβ ratios in autosomal dominant Alzheimer’s disease: the influence of genotype
    Antoinette O’Connor, Josef Pannee, Teresa Poole, Charles Arber, Erik Portelius, Imogen J. Swift, Amanda Heslegrave, Emily Abel, Nanet Willumsen, Helen Rice et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Inhibitory proteins block substrate access by occupying the active site cleft of Bacillus subtilis intramembrane protease SpoIVFB
    Sandra Olenic, Lim Heo, Michael Feig, Lee Kroos · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Alzheimer mutations stabilize synaptotoxic γ-secretase-substrate complexes
    Sujan Devkota, Rui Zhou, Vaishnavi Nagarajan, Masato Maesako, Hung Nguyen Do, Arshad Ali Noorani, Caitlin Overmeyer, Sanjay Bhattarai, Justin T. Douglas, Anita Saraf et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Mitochondrial Dynamics and Bioenergetics in iPSC-Derived Neurons with Familial Alzheimer’s Disease Mutations
    Courtney MacMullen, Neelam Sharma, Ronald L. Davis · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  16. Taking a position on intramembrane proteolysis
    M. Joanne Lemieux · 2018 · Journal of Biological Chemistry
  17. Exploring the origins of nucleation
    Katarzyna Marta Zoltowska, Lucía Chávez‐Gutiérrez · 2021 · eLife
  18. Membrane compartmentalization by adherens junctions creates a spatial switch for Notch signaling and function
    Minsuk Kwak, Kaden M. Southard, Woon Ryoung Kim, Annie Lin, Nam Hyeong Kim, Ramu Gopalappa, Minji An, Hyun Jung Lee, Seo Hyun Choi, Justin Farlow et al. · 2021 · Research Square
  19. Characterisation of the ghrelinergic system in human models of neurodegenerative diseases
    Maria Carla Carisi · 2021
  20. Active site geometry stabilization of a presenilin homolog by the lipid bilayer promotes intramembrane proteolysis
    Lukas P. Feilen, Shuyu Chen, Akio Fukumori, Regina Feederle, Martin Zacharias, Harald Steiner · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Psychiatric Disorders in Dementia
    Yannick Vermeiren, Debby Van Dam, Maartje de Vries, Peter Paul De Deyn · 2020 · Springer eBooks
  22. Finding Cures for Alzheimer's Disease
    Xianhai Huang, Robert G. Aslanian · 2022 · Wiley eBooks
  23. References
    2018 · Elsevier eBooks
  24. APP substrate ectodomain defines Aβ length by restraining γ-secretase processivity and facilitating product release
    Matthias K. Koch, Thomas Enzlein, Shuyu Chen, Dieter Petit, Sam Lismont, Martin Zacharias, Carsten Hopf, Lucía Chávez‐Gutiérrez · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling
    Katarzyna Marta Zoltowska, Utpal Das, Sam Lismont, Thomas Enzlein, Masato Maesako, CQ Houser Mei, María Luisa Franco, Diana Gomes Moreira, Dmitry Karachentsev, Ann Becker et al. · 2023 · eLife
  26. Resistance to PSEN1-selective γ-secretase inhibitors in T-cell acute lymphoblastic leukemia
    Charlien Vandersmissen, Sofie Demeyer, Kris Jacobs, Lien Boogaerts, Sara Gutiérrez Fernández, Heidi Segers, Lucía Chávez‐Gutiérrez, Jan Cools · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling
    Katarzyna Marta Zoltowska, Utpal Das, Sam Lismont, Thomas Enzlein, Masato Maesako, Mei CQ Houser, María Luisa Franco, Burcu Özcan, Diana Gomes Moreira, Dmitry Karachentsev et al. · 2024 · eLife
  28. Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling
    Katarzyna Marta Zoltowska, Utpal Das, Sam Lismont, Thomas Enzlein, Masato Maesako, Mei CQ Houser, María Luisa Franco, Burcu Özcan, Diana Gomes Moreira, Dmitry Karachentsev et al. · 2024 · eLife
  29. Application of genome editing to the treatment of familial AD
    Takaomi C. Saido · 2024 · Elsevier eBooks
  30. A Neuroinflammatory View of Alzheimer’s Disease
    Hymie Anisman, Shawn P. Hayley, Alexander Kusnecov · 2024 · Elsevier eBooks
  31. References
    2024 · Elsevier eBooks
  32. Down Syndrome: Progress in Defining Pathogenesis and Treatments for Neurodevelopmental Deficits and Alzheimer’s Disease
    Renata Bartesaghi, Xu‐Qiao Chen, Aaron D. Johnstone, Utpal Das, William Cary Mobley · 2025 · Springer eBooks
  33. Co-occurrence of primary familial brain calcification from a likely pathogenic SLC20A2 variant and Alzheimer’s disease biology
    Hyuk-je Lee, Sang‐Won Yoo, Myungshin Kim, Hoon Seok Kim, Joong‐Seok Kim · 2025 · Neurocase
  34. Kat5 cKO Biological Domain Signatures Align with Human Alzheimer’s Disease
    Gregory A. Cary, Jessica E. Young, Shannon E. Rose, Harald Frankowski, Martin Darvas, Mark Bothwell, Suman Jayadev, Aquene N. Reid, Anna K. Greenwood, Allan I. Levey et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  35. The curious case of a heterozygous loss-of-function PSEN1 variant associated with early-onset Alzheimer’s disease
    Inmaculada Sanjuan-Ruiz, Lutgarde Serneels, Katleen Craessaerts, Alison Goate, Wim G. Annaert, Lucía Chávez‐Gutiérrez, Yonggang Shi, Nasim Sheikh‐Bahaei, Joanna C. Jen, Eliana Marisa Ramos et al. · 2025 · Molecular Neurodegeneration Advances
  36. The relationship between amyloid-β peptide spectrum and the spastic paraparesis phenotype in autosomal dominant Alzheimer’s disease
    Katarzyna Marta Zoltowska, Julia Bandera, Mohamed Belal Hamed, Thomas Enzlein, Carsten Hopf, Natalie Sarah Ryan, Lucía Chávez‐Gutiérrez · 2025 · Alzheimer s Research & Therapy
  37. In Silico Phosphoproteomic Analysis Reveals Divergent Regulation of Presenilin 1 and Presenilin 2
    Sadia Begum, Javier de Andrés Álvarez, Claudia Manzoni, Charles Arber, Patrick Alfryn Lewis · 2026 · NeuroMolecular Medicine
  38. Correlations of 276 missense variants of PSEN1, PSEN2 , and APP on the production of Aβ peptides against variant effect predictors and biophysical structures
    J. J. Song, Serina Yan, Sophia Liu, Adhvaith Sridhar, Kijung Sung, Joshua P. Pillai, Chengbiao Wu · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Les APP-CTFs au cœur du processus pathologique de la maladie d’Alzheimer : contribution du système lysosomal-autophagique et de la sécrétion exosomale
    Anaïs Bécot · 2019 · theses.fr (ABES)
  40. Influences biochimiques, anatomiques et cognitives de la troncation exopeptidasique N-terminale du peptide Aβ
    Audrey Valverde · 2020 · theses.fr (ABES)
  41. Synaptic plasticity in a memory circuit : physiological and pathophysiological role of the amyloid precursor protein
    Ana Moreira-de-Sá · 2024 · theses.fr (ABES)
  42. Membrane protein folding, misfolding, and quality control
    Eojin Kim, Seoyoon Kim, Minseung Kim, Duyoung Min · 2026 · Elsevier eBooks
  43. Comparative performance of semi-quantitative methods for amyloid deposition in preclinical autosomal dominant Alzheimer’s disease
    Zhi Zhou, Jin Gao, Qi Wang, Qigeng Wang, Lu Liu, Xiaojun Zhang, Can Li, Jiajin Liu, Yidan Wei, Shixiang Zhang et al. · 2026 · Alzheimer s Research & Therapy
  44. Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease
    Gregory A. Cary, Jessica E. Young, Shannon E. Rose, Harald Frankowski, Heather Wilkins, Sai Sruthi Amirtha Ganesh, Julia M. Draper, Martin Darvas, Mark Bothwell, Suman Jayadev et al. · 2026 · Alzheimer s & Dementia
  45. Genetic and structural characterisation of alzheimer’s disease associated variants in an Eastern Indian cohort
    Dipanwita Sadhukhan, Adreesh Mukherjee, Izaz Monir Kamal, Shreyosi Maitra, Brahmachari Somnath Vedeshachaitanya, Bidisha Bhattacharyya, Atanu Biswas, Saikat Chakrabarti, Arindam Biswas · 2026 · Metabolic Brain Disease
  46. Neuroinflammatory and molecular pathways in Alzheimer’s disease: mechanistic crosstalk and emerging therapeutic opportunities
    Abhay Thakur, Rohit R. Sharma, Sneha Kumari, Dev Prakash, A Sanjana Devi · 2026 · Inflammopharmacology
  47. Correlations of PSEN1 , PSEN2 , and APP missense variants on the production of Aβ peptides against variant effect prediction
    J. J. Song, Serina Yan, Sophia Liu, Adhvaith Sridhar, Kijung Sung, Joshua Pillai, Chengbiao Wu · 2026 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  48. The right temperature at the right time: A framework for understanding thermoregulatory pathophysiology in Alzheimer's disease
    Esther Blessing · 2026 · Alzheimer s & Dementia
  49. BindingDB Entry 50002402: Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.
    BindingDB · 2020 · UC San Diego